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ABSTRACT
Oral lichen planus (OLP) is a rather common oral disease, mainly affecting adults, occurring more often in women 
than in men. The etiopathogenesis is still unclear. The diagnosis may be cumbersome, even in the presence of a 
biopsy. In addition, there are several lesions that may resemble lichen planus (lichenoid lesions) both clinically 
and histopathologically. Treatment of OLP can only be symptomatic and usually consists of topical application 
of corticosteroids. The disease is characterized by remissions and exacerbations and may persist in some patients 
lifelong. There is an ongoing debate in the literature as whether OLP is a potentially malignant disease. Because 
of this uncertainty, annual follow-up is advised.
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INTRODUCTION
Lichen planus (LP) is a chronic mucocutaneous 
disorder which may involve the oral mucosa only 
(“isolated OLP”) or in combination with involvement 
of other mucosal surfaces, e.g. vagina (“vulvovaginal-
gingival syndrome”), oesophagus, pharynx, and nails. 
It has been suggested that extra-oral involvement in oral 
lichen planus is more common than suspected.1,2  A few 
cases have been reported of transformation of OLP into 
mucous membrane pemphigoid, being referred to as 
lichen planus pemphigoides.3 Attention will be paid at 
the diagnostic aspects of OLP and lichenoid lesions, as 
well at the various treatment modalities. An important 
question whether OLP is a benign lesion or a potentially 
malignant one.
Epidemiology
The estimated prevalence of oral lichen planus is 
approximately 0.1 %, although figures varying from 
1% to 4% have been reported in the literature.4 Oral 
lichen planus mainly affects middle-aged people and 
is more common among women than among men.5 
Familial presentation is extremely rare.6 Oral lichen 
planus occurs mainly in non-smokers.7  Little is known 
about possible geographic differences.
Etiology
Lichen planus is most likely caused by T- cell autoimmu-
nity. Apparently, Langerhans cells play an important role in 
this process.8 Controversial views have been reported about 
the role of human papilloma virus (HPV), particularly 
HPV 16.9,10 There is no evidence that psychological factors 
are a direct etiological factor. In some populations there is 
a significant, yet unexplained, association between lichen 
planus and hepatitis C virus.11 Yet, in other populations an 
association with thyroid diseases, especially hypothyroid-
ism, has been reported.12 
Lichen planus or lichen planus-like lesions, usually 
referred to as lichenoid lesions or lichenoid reactions, 
may occasionally be caused by certain drugs.13 Also 
prolonged, direct anatomic contact with large amalgam 
restorations (“contact lesion”) may produce a lichenoid 
appearance of the oral mucosa. Furthermore, a chronic 
graft versus host reaction after an allogenic stem cell 
transplantation may strongly resemble OLP. Interestingly, 
the lower lip is a site of predilection in this particular 
patient population.
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Clinical aspects
Signs and symptoms
Oral lichen planus has various clinical manifestations, 
such as reticular (characterized by white striae, also 
referred to as “Wickhams striae”), annular, papular, 
erythematous, plaque- type, ulcerative and bullous 
type. The reticular, the erythematous and the plaque 
types are the most common ones. The various types 
may occur simultaneously in an individual patient and 
may also change in time. (Figure. 1 and 2).  It has been 
suggested that the plaque type is more common among 
smokers. There is nearly always a bilateral, more or 
less symmetrical distribution. The buccal mucosa, the 
gingiva and the dorsal surface of the tongue are the 
sites of predilection. Occurrence in the floor of the 
mouth and the palate is rare. Superficial mucoceles 
may develop within or adjacent to mucosal areas that 
are involved by lichen planus, while in dark-skinned 
people post-inflammatory melanosis  has been reported 
to occur in the affected areas. 
Par ticularly the erythematous type may cause 
symptoms, such as pain and, in case of gingival 
involvement, severe bleeding during toothbrushing. 
Patients affected by the erythematous or ulcerative 
type of OLP usually do not tolerate spicy food. When 
the gums are involved patients may complain about 
the esthetic aspect of their gums. In involvement of 
the gingiva the presence of the “vulvovaginal gingiva 
syndrome” should be considered.
The course of oral lichen planus is characterized by 
remissions and exacerbations with intervals of several 
weeks or months of both the clinical signs and the 
symptoms. There are various scoring systems, mainly 
designed for scientific studies, to quantify the clinical 
signs and symptoms of OLP.14 
Clinical differential diagnosis, including lichenoid 
lesions
Llichenoid lesions may be caused by direct anatomic 
contact with a large (amalgam) restoration. Replacement 
of the restoration should result in healing of the lesion 
within several weeks, but this should be checked by 
the clinician. One may consider to take a biopsy before 
advising to have the amalgam restoration removed in 
order to exclude the possibility of a dysplastic or even a 
malignant lesion. The predictive value of epicutaneous 
patch testing for amalgam and mercury allergy is rather 
questionable.15,16   In contrast todrug-induced cutaneous 
lichenoid lesions drug-induced oral lichenoid lesions 
are extremely rare. Nevertheless, one may consider to 
adjust the medication (Box 1), if applicable. Of course, 
such adjustment requires communication with the 
prescribing specialist.
As has been mentioned already, lichenoid lesions may 
occur in chronic graft-versus-host disease, being clinically 
sometimes indistinguishable from “idiopathic” OLP. At 
times, it may be difficult, if not impossible, to clinically 
distinguish oral lichen planus not only from lichenoid 
lesions but also from leukoplakia, lupus erythematodes, 
linear IgA disease, mucous membrane pemphigoid and 
some other white or red lesions of the oral mucosa.17 In 
some of these cases the medical history or other clinical 
features are helpful in establishing the correct diagnosis. 
Unfortunately, a biopsy is not always helpful in such 
cases. Some clinicians will always do a biopsy in case 
of oral lichen planus, while others take a biopsy only 
in case of doubt about the diagnosis. 
Histopathology
In case of a distinct clinical diagnosis of lichen planus the 
histopathologic features are usually quite characteristic 
(Figure 3.). In scientific studies usually reference is made 
Figure 2. A 58-year-old woman with a somewhat plaque-type 
OLP at the lateral border of the tongue (a); after six weeks 
there is a distinct reticular pattern (b).
Figure 1. A 55-year-old woman with plaque-type OLP of the 
tongue (a), erythematous type of the gums (b) and reticular 
type on the buccal mucosa (c and d).
(a)
(c)
(a)
(b)
(d)
(b)
Box 1. Drugs possibly causing lichenoid lesions13
Antihypertensives (e.g. ACE inhibitors)
Oral hypoglycaemics (e.g. Tolbutamide)
Non-steroidal anti-inflammatory drugs
Second line anti-arthritics (gold; penicillamine)
Xanthine oxidase inhibitors (Allopurinol)
Psychoactive drugs (e.g. tricyclic antidepressants)
Diuretics (e.g. furosamide)
Antiparasitic drugs 
Antimicrobial agents,including mouthr inses (e.g. 
tetracycline)
Miscellaneous drugs (e.g. iodides, quinidine)
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Is oral lichen planus potentially malignant and can 
such event be prevented?
Oral lichen planus is by some regarded as a premalignant 
condition, the annual malignant transformation rate 
being less than 1%.21 If this event occurs, it usually 
concerns the tongue.6 The suggestion has been made 
that a certain cell surface marker on hematopoietic stem 
cells and early progenitor cells in the bone marrow, 
referred to as CD133, correlates with the progression 
to oral squamous cell carcinoma.22 
Others have not found any evidence for a potentially 
malignant behavior.23 Anyhow, such malignant 
transformation can not be prevented, although it has 
been speculated that the use of topical steroids may 
prevent such event.24 
Treatment
Oral lichen planus may last for many years, if not 
lifelong.25 There is no cure for oral lichen planus. 
Treatment can only be symptomatic and most 
commonly consists of topical or, occasionally systemic, 
corticosteroids. The use of corticosteroids may enhance 
the risk of the development of candidiasis, sometimes 
necessitating antimycotic therapy. 
Also the use of many other drugs, e.g. tacrolimus, 
thalidomide, topical aloe vera, oral curcuminoids and 
lysopine has been reported.26 The efficacy of all these 
drugs is  rather questionable.27 There are opposing views 
about the effect of removing all amalgam restorations, 
not just the ones directly related to a lesion.28,29 It has 
been shown that plaque control improves the symptoms 
of OLP with gingival involvement.30 
A variety of other treatment modalities has been 
reported, such as surgical excision, laser evaporation, 
laser excision and photodynamic treatment. Such 
treatment modalities may be useful in persistent 
localized areas of lichenoid involvement. 
Follow-up
Since the issue of premalignancy is still under debate, it 
seems safe practice to check the patient annually for any 
possible unfavorable change. However, it is questionable 
whether such follow-up is really effective in either 
preventing malignant transformation or in resulting in 
better survival in case of cancer development. 
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